Work

Phase 2 multicenter clinical trial to evaluate the safety and efficacy of abenacianine for injection (VGT-309), a tumor-targeted, intraoperative molecular imaging agent, for patients undergoing surgery for cancer in the lung.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.3069

Authors: Sunil Singhal, Luis J. Herrera, Gavin Michael Wright, Jae Y. Kim, Janani S Reisenauer, David C. Rice

Institutions: University of Pennsylvania, Orlando Health, St Vincent's Hospital Melbourne, City Of Hope National Medical Center, City of Hope, Mayo Clinic, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Optical Imaging and Spectroscopy Techniques

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410812923

Cites:

Cited by: 1

Related to: 10